LigaChem Biosciences

141080.KQ

52.48 USD

-1.33

-2.47%

Overview

Last close

52.48 usd

Market cap

1.93B usd

52 week high

146.05 usd

52 week low

46.51 usd

Target price

157.29 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

26.3733

Price/Book Value

7.4405

Enterprise Value

1.96B usd

EV/Revenue

26.2812

EV/EBITDA

5044.2569

Key financials

Revenue TTM

74.70M usd

Gross Profit TTM

65.45M usd

EBITDA TTM

-150.40M usd

Earnings per Share

-3.67 usd

Dividend

N/A usd

Total assets

383.92M usd

Net debt

N/A usd

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.